European Biotechnology: “A pioneering real AI drug discovery technology”

posted on November 26, 2020
A pioneering real AI drug discovery technology
European Biotechnology: "A pioneering real AI drug discovery technology"
European Biotechnology Life Science and Industry Magazine published the article "A pioneering real AI drug discovery technology" describing the approach of SOM Biotech. The current COVID-19 pandemic situation has shown that repurposing drugs can be crucial for delivering new treatments to patients with agility. Existing drugs can be developed to bring fast, safe and cost-effective…
continue reading →

La Vanguardia press release: “The future of biotechnology: lower-cost treatments in a short period of time”

posted on November 26, 2020
La Vanguardia press release: "The future of biotechnology: lower-cost treatments in a short period of time"
La Vanguardia published a press release: "The future of biotechnology: lower-cost treatments in a short period of time". You can find a short overview of the press release below. SOM Biotech has designed a computational Artificial Intelligence-based method to analyze molecular structures and select the best option after performing more than 2.5 million comparisons in…
continue reading →

SOM Biotech keynote speaker at the Drug Discovery Innovation Programme Virtual Event 2020

posted on November 16, 2020
SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech announces its participation at the Drug Discovery Innovation Programme event 2020, being held virtually on November 17th. The conference will be chaired by Kevin McAllister, PhD, MBA Chief Scientific Officer. As a keynote speaker, Maria Zimina, PhD. MBA, Business Development Manager, will present “AI Evolutionary Algorithms for the Identification of Non-Structural Analogs: Case…
continue reading →

SOM Biotech presents its drug candidate for the Chorea in Huntington Disease at the XIX Pharma – Biotech Cooperation conference

posted on November 10, 2020
SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech presents its drug candidate SOM3355 for the Chorea in Huntington Disease at the XIX Pharma-Biotech Cooperation conference, November 12th 2020. The conference, an initiative of Farmaindustria - the National Trade Association of the Spanish based pharmaceutical industry -  allows companies previously selected for their contribution to innovation, to present their drug development projects to…
continue reading →

SOM Biotech at BIO-Europe 2020 Digital Convention

posted on October 20, 2020
SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech will attend the “BIO-Europe 2020” convention on October 26th – 29th, which will take place digitally due to the pandemic situation. Raúl Insa, CEO of SOM Biotech: “BIO-Europe 2020 is one of the most relevant partnering events for the life science sector. We look forward to meeting with potential partners and qualified investors…
continue reading →

SOM Biotech announces poster presentation on the repurposing of Eravacycline for the treatment of SARS-CoV-2

posted on October 19, 2020
SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech announces today that it will present in silico and in vitro results regarding Eravacycline for the treatment of SARS-CoV-2 during a virtual poster presentation at the IDWeek 2020. The poster is entitled “Repurposing of Eravacycline for the Treatment of SARS-CoV-2 Infections”. It outlines pre-clinical data demonstrating that Eravacycline is a potent inhibitor of…
continue reading →